Genome editing

Genome editing is the manipulation of DNA in the genome of a living organism. The theme has shot to prominence in the wake of COVID-19, with the excitement surrounding the potential testing applications of CRISPR technology. ETFs in this space give investors exposure to Bioinformatics, Targeted Therapeutics & Molecular Diagnostics.

LiveClosed Updated: Refresh

ThemeDayWeekMonthYear# Assets

Past performance is not a reliable indicator of future results. All themes

Load More